Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 101, P. 106224 - 106224
Published: Sept. 21, 2024
Language: Английский
Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 101, P. 106224 - 106224
Published: Sept. 21, 2024
Language: Английский
Advanced Materials Interfaces, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 5, 2025
Abstract Rapid advances in the development of nanotechnology recent years have led to functional magnetic nanoparticle types (MNPs) with different properties. The diverse applications these nanoparticles make them a desirable candidate for use biomedical areas due their exclusive chemical and physical present work is conducted study vitro biocompatibility CoFe 2 O 4 @shell surface coatings (shell: ascorbic acid (AA), dextran (DEX), polyethyleneimine (PEI). cytotoxicity coated screened toward glioma cancer line (C6) fibroblast cell (L929) using an MTT assay. NPs are synthesized co‐precipitation method together hydrothermal synthesis characterized regarding structural properties state‐of‐the‐art techniques. Results showed particles consistent crystal structure average crystallite size range 16–18 nm. For NPs, only slight increase Hc found except @PEI NPs. comparative analysis cytotoxic effects on L929 cells shows that samples much more specific brain tumor cells, especially it also indicates significant efficacy cells.
Language: Английский
Citations
1Drug Development and Industrial Pharmacy, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 14
Published: Aug. 5, 2024
Cancers are regarded as hazardous due to their high worldwide death rate, with breast cancer (BC), which affects practically all patients globally, playing a significant role in this statistic. The therapeutic approach for BC has not advanced using standard techniques, such specialized naringin (NG) chemotherapy. Instead, novel strategy been utilized enhance smart drug delivery (SDD) tumors.
Language: Английский
Citations
7Drug Development and Industrial Pharmacy, Journal Year: 2024, Volume and Issue: 50(7), P. 671 - 686
Published: July 2, 2024
This study was aimed to develop a cationic lipoplex formulation loaded with Nintedanib and miR-29b (LP-NIN-miR) as an alternative approach in the combination therapy of idiopathic pulmonary dibrosis (IPF) by proving its additive anti-fibrotic therapeutic effects through
Language: Английский
Citations
1Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 101, P. 106224 - 106224
Published: Sept. 21, 2024
Language: Английский
Citations
0